Panagora Asset Management Inc Fate Therapeutics Inc Transaction History

Panagora Asset Management Inc

$21 Billion
Q4 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$1.65 - $3.94 $115,244 - $275,189	-69,845 Reduced 16.37%	356,740 $1.33 Million
Q3 2023 Oct 31, 2023	BUY	$2.02 - $5.04 $216,337 - $539,773	107,098 Added 33.52%	426,585 $904,000
Q2 2023 Aug 11, 2023	SELL	$4.76 - $6.59 $27,960 - $38,709	-5,874 Reduced 1.81%	319,487 $1.52 Million
Q1 2023 May 11, 2023	BUY	$4.24 - $11.12 $21,373 - $56,055	5,041 Added 1.57%	325,361 $1.85 Million
Q4 2022 Feb 13, 2023	BUY	$9.86 - $23.83 $217,334 - $525,260	22,042 Added 7.39%	320,320 $3.23 Million
Q3 2022 Nov 14, 2022	SELL	$21.04 - $36.06 $49,948 - $85,606	-2,374 Reduced 0.79%	298,278 $6.68 Million
Q2 2022 Aug 15, 2022	BUY	$17.78 - $42.39 $448,180 - $1.07 Million	25,207 Added 9.15%	300,652 $7.45 Million
Q1 2022 May 12, 2022	BUY	$29.67 - $60.28 $18,276 - $37,132	616 Added 0.22%	275,445 $10.7 Million
Q4 2021 Feb 10, 2022	BUY	$47.84 - $64.34 $452,375 - $608,399	9,456 Added 3.56%	274,829 $16.1 Million
Q3 2021 Nov 10, 2021	BUY	$59.27 - $95.73 $1.98 Million - $3.2 Million	33,473 Added 14.43%	265,373 $15.7 Million
Q2 2021 Aug 11, 2021	BUY	$67.25 - $92.52 $4.66 Million - $6.41 Million	69,304 Added 42.62%	231,900 $20.1 Million
Q1 2021 May 12, 2021	BUY	$72.16 - $117.4 $11.7 Million - $19.1 Million	162,596 New	162,596 $13.4 Million
Q3 2018 Nov 13, 2018	SELL	$8.75 - $16.29 $54,906 - $102,219	-6,275 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$9.16 - $13.48 $45,470 - $66,914	-4,964 Reduced 44.17%	6,275 $71,000
Q1 2018 May 15, 2018	SELL	$6.3 - $13.77 $77,011 - $168,324	-12,224 Reduced 52.1%	11,239 $110,000
Q4 2017 Feb 14, 2018	SELL	$3.94 - $6.64 $126 - $212	-32 Reduced 0.14%	23,463 $143,000
Q3 2017 Nov 14, 2017	BUY	$2.6 - $4.31 $61,087 - $101,263	23,495	23,495 $93,000

Others Institutions Holding FATE

# of Institutions

167

Shares Held

101M

Call Options Held

41.3K

Put Options Held

15.9K

Redmile Group, LLC San Francisco, CA

12.9M
Shares

$13.3 Million
1.66% of portfolio
Vanguard Group Inc Valley Forge, PA

10.3M
Shares

$10.6 Million
0.0% of portfolio
Black Rock Inc. New York, NY

10.1M
Shares

$10.4 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

4.84M
Shares

$4.98 Million
0.16% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

4.38M
Shares

$4.51 Million
0.0% of portfolio

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $99.9M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account